AAAdrhyan Araújo

Adrhyan Araújo

*This is an algorithmically generated author record based on publicly available information.

Adrhyan Araújo has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aspectos epidemiológicos da esquizofrenia em um CAPS de Rondônia, Brasil

    by Ana Luiza Ricci dos Santos, Maria Eduarda Ripke de Negreiros, Nicoly Maciel Pacheco, Adrhyan Araújo, Deusilene Vieira

    ResumenIntroducción. La esquizofrenia es un trastorno neuropsiquiátrico que altera la percepción, el pensamiento, las emociones y la conciencia. Es la forma más común de psicosis, afectando a aproximadamente 20 millones de personas en todo el mundo. Objetivo. Identificar el perfil epidemiológico de los pacientes diagnosticados con esquizofrenia en Porto Velho, Rondônia. Método. Se trata de un estudio descriptivo, transversal, con un enfoque cualitativo-cuantitativo, realizado en un Centro de Atención Psicosocial (CAPS). Resultados. Se recopilaron datos de 200 historias clínicas de pacientes activos, enfocándose en variables como sexo, edad, estado civil, nivel educativo, religión, diagnóstico CIE-10, tratamiento farmacológico y antecedentes familiares. De estos, 47 registros (23,5%) correspondían a trastornos del espectro de la esquizofrenia (CIE-10: F20–F29), con un 53,2% de hombres y un 46,8% de mujeres, y una edad media de 45±3 años. La mayoría de los pacientes eran solteros (57,4%), no habían completado la educación primaria (38,3%) y se identificaban como católicos o evangélicos (27,7% cada uno). La esquizofrenia no especificada (F20) (40,43%) y la esquizofrenia paranoide (F20.0) (17,02%) fueron los diagnósticos más frecuentes. El tratamiento farmacológico se registró en el 97,9% de los casos, y el 9% tenía antecedentes familiares de enfermedad mental. Conclusión. Comprender este perfil contribuye a una mejor planificación de estrategias de salud pública y al fortalecimiento de los servicios de salud mental.

  • Open Access

    Evaluation of HDV stability under different biological sample collection and storage conditions: implications for molecular diagnosis

    by Jackson Alves da Silva Queiroz, Mônica Barcellos Arruda, Tárcio Peixoto Roca, Adrhyan Araújo, Ana Maísa Passos-Silva, Eugênia de Castro e Silva, Lourdes Maria Pinheiro Borzacov, Alexandre Rodrigues Calazans, Juan Miguel Villalobos Salcedo, Patrícia Alvarez da Silva Baptista, et al.

    In Brazil, the Amazon region has the highest rate of infection by the hepatitis Delta virus, and owing to regional difficulties in transporting and storing samples, especially in remote regions and isolated populations, the expansion of molecular diagnosis has become a significant public health problem. This study aims to analyze the stability of HDV under different temperature and storage conditions, providing essential information for the expansion of the molecular diagnosis of Hepatitis Delta. Whole blood, serum, and plasma samples were collected from chronic HDV patients. The samples were subjected to different temperatures and storage conditions, and HDV-RNA detection was performed via RT-qPCR. HDV was stable under various temperature conditions, including high temperatures, with minimal variations in Ct values. Compared with cryopreserved samples, DBS samples presented greater variation. The results suggest that HDV can remain detectable for up to 96 h when stored at room temperature, 4 °C, -30 °C, and − 80 °C and for up to 72 h at temperatures ranging from 4 °C to 42 °C, in addition to the possibility of detection via filter paper, although with reduced sensitivity. HDV is stable under different conditions, which is crucial for molecular diagnostics in regions with adverse storage conditions.


  • Open Access

    Screening Biomarkers and Risk Factors for COVID-19 Progression in a Border Population Between Brazil-Bolivia

    by Ana Maísa Passos-Silva, Adrhyan Araújo, Tárcio Peixoto Roca, Jackson Alves da Silva Queiroz, Gabriella Sgorlon, Rita de Cássia Pontello Rampazzo, Juan Miguel Villalobos Salcedo, Juliana Pavan Zuliani, Deusilene Vieira

    Background: The performance and genetic role in host response delineate investigative points of polymorphisms as potential biomarkers in viral infections. Methods: Thus, this research aimed to map biomarkers and risk factors in the severity of COVID-19 in individuals in Western Amazon (n = 243). Results: Patients aged 40 to 59 years showed an association with clinical progression ( P = .003), also evidencing the relationship for individuals >60 years ( P < .001), besides the non-vaccination influenced the pathology ( P = .023). qPCR for human genotyping of the targets rs2070788, rs4702, rs76635825, rs540856718, rs35803318, rs12979860, and rs16899066, as well as for gene expression of ACE2, HLA-A, HLA-B, IFNL-3/2, IL-6, and TMPRSS2 was used. The rs12979860 (C > T) and rs2070788 (A > G) showed association among the analyzed groups ( P < .05) with the allelic and genotypic frequency of rs12979860 ( x 2 < 3.84) and evolutionary pointing of rs2070788G allele among infected people, including deaths. Conclusion: Gene expression showed high levels between the moderate and severe groups, with emphasis on TMPRSS2 and IL-6 genes that performed better. Thus, there is possibly an association regarding the role of the TMPRSS2 gene and rs2070788G, as well as age and IL-6 levels for COVID-19, pointing in parallel to the considerable influence of the vaccine on the SARS-CoV-2 pathway.

  • Open Access

    Molecular genetic association of rs8099917 and rs1800795 polymorphisms in the progression of hepatitis Delta virus liver disease

    by Ana Maísa Passos-Silva, Eugênia de Castro e Silva, Lourdes Maria Pinheiro Borzacov, Adrhyan Araújo, Anita Sperandio Porto, Juan Miguel Villalobos Salcedo, Deusilene Vieira

    The relationship between viral infections and host factors holds high hopes for identifying the role of Interferon Lambda 3 (IFNL3) and Interleukin 6 (IL-6) polymorphisms in the development of Chronic Liver Disease (CLD) in patients infected with hepatitis Delta virus (HDV) in the Western Brazilian Amazon.